BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6240447)

  • 1. Reversal of cardiac hypertrophy in humans.
    Tarazi RC; Fouad FM
    Hypertension; 1984; 6(6 Pt 2):III140-6. PubMed ID: 6240447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cardiac hypertrophy by medical treatment.
    Tarazi RC; Fouad FM
    Annu Rev Med; 1985; 36():407-14. PubMed ID: 3158269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac determinants of regression of left ventricular hypertrophy in essential hypertension with antihypertensive treatment.
    Sugishita Y; Iida K; Yukisada K; Ito I
    J Am Coll Cardiol; 1990 Mar; 15(3):665-71. PubMed ID: 2137479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of cardiac function, geometry, energetics and coronary reserve in hypertensive heart disease.
    Strauer BE
    Nephron; 1987; 47 Suppl 1():76-86. PubMed ID: 2962004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy regression and function changes with ketanserin in elderly hypertensives.
    Vyssoulis GP; Karpanou EA; Pitsavos CE; Paleologos AA; Kourtis TK; Toutouzas PK
    Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():81-4. PubMed ID: 2149517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of structural cardiovascular changes by antihypertensive therapy.
    Motz W; Strauer BE
    Hypertension; 1984; 6(6 Pt 2):III133-9. PubMed ID: 6240446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy.
    Liebson PR
    Am J Hypertens; 1990 Jun; 3(6 Pt 1):512-7. PubMed ID: 2142430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired left ventricular functional reserve in hypertensive patients with left ventricular hypertrophy.
    Tubau JF; Szlachcic J; Braun S; Massie BM
    Hypertension; 1989 Jul; 14(1):1-8. PubMed ID: 2525526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of cardiac hypertrophy with drug treatment in spontaneously hypertensive rats.
    Ruskoaho H
    Med Biol; 1984; 62(5):263-76. PubMed ID: 6152298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression of left ventricular hypertrophy from systemic hypertension by enalapril.
    Nakashima Y; Fouad FM; Tarazi RC
    Am J Cardiol; 1984 Apr; 53(8):1044-9. PubMed ID: 6322566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac function in systemic hypertension before and after reversal of left ventricular hypertrophy.
    Trimarco B; De Luca N; Ricciardelli B; Rosiello G; Volpe M; Condorelli G; Lembo G; Condorelli M
    Am J Cardiol; 1988 Oct; 62(10 Pt 1):745-50. PubMed ID: 2971309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy by medical treatment: present status and possible implications.
    Tarazi RC
    Am J Med; 1983 Sep; 75(3A):80-6. PubMed ID: 6226199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.
    Angermann CE; Spes CH; Willems S; Dominiak P; Kemkes BM; Theisen K
    Circulation; 1991 Aug; 84(2):583-93. PubMed ID: 1830519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).
    Malmqvist K; Kahan T; Edner M; Bergfeldt L
    Am J Cardiol; 2002 Nov; 90(10):1107-12. PubMed ID: 12423712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of cardiac hypertrophy. Experimental animal model.
    Sen S
    Am J Med; 1983 Sep; 75(3A):87-93. PubMed ID: 6137950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Ventricular Hypertrophy in Hypertensive Athletes can be Reduced by Antihypertensive Medication Despite Continuing Intense Aerobic Exercise.
    Ketelhut S; Franz IW; Ketelhut RG
    High Blood Press Cardiovasc Prev; 2018 Dec; 25(4):385-390. PubMed ID: 30341642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in midwall myocardial shortening with regression of left ventricular hypertrophy.
    Mayet J; Ariff B; Wasan B; Chapman N; Shahi M; Poulter NR; Sever PS; Foale RA; Thom SA
    Hypertension; 2000 Nov; 36(5):755-9. PubMed ID: 11082139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy.
    Cruickshank JM; Lewis J; Moore V; Dodd C
    J Hum Hypertens; 1992 Apr; 6(2):85-90. PubMed ID: 1534582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.